Kymera Therapeutics, Inc.KYMRNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
1.05%
↑ 108% above average
Average (24q)
-13.45%
Historical baseline
Range
High:72.22%
Low:-176.00%
Volatility
-1846.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 1.05% |
| Q2 2025 | -15.85% |
| Q1 2025 | 6.82% |
| Q4 2024 | -7.32% |
| Q3 2024 | -41.38% |
| Q2 2024 | 15.94% |
| Q1 2024 | -176.00% |
| Q4 2023 | 72.22% |
| Q3 2023 | -34.33% |
| Q2 2023 | -6.35% |
| Q1 2023 | -6.78% |
| Q4 2022 | 25.32% |
| Q3 2022 | -2.60% |
| Q2 2022 | -8.45% |
| Q1 2022 | -7.58% |
| Q4 2021 | -17.86% |
| Q3 2021 | -1.82% |
| Q2 2021 | -89.66% |
| Q1 2021 | 0.00% |
| Q4 2020 | -61.11% |
| Q3 2020 | 43.75% |
| Q2 2020 | -28.00% |
| Q1 2020 | 3.85% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |